Article Details

FDA revises labeling of Biogen's Alzheimer's drug to emphasize early treatment

Retrieved on: 2021-07-08 14:15:00

Tags for this article:

Click the tags to see associated articles and topics

FDA revises labeling of Biogen's Alzheimer's drug to emphasize early treatment. View article details on hiswai:

Excerpt

BioPharma Dive Congress pressures FDA and Biogen on Alzheimer's drug approval, price offsite link. Follow Ned Pagliarulo on Twitter. Follow Ben ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up